Your browser is no longer supported. Please, upgrade your browser.
DXCM DexCom, Inc. weekly Stock Chart
DXCM [NASD]
DexCom, Inc.
Index- P/E- EPS (ttm)-1.93 Insider Own1.10% Shs Outstand91.10M Perf Week6.98%
Market Cap15.33B Forward P/E120.37 EPS next Y1.40 Insider Trans-17.39% Shs Float90.64M Perf Month8.49%
Income-170.90M PEG- EPS next Q0.23 Inst Own95.30% Short Float5.84% Perf Quarter41.90%
Sales1.22B P/S12.55 EPS this Y-324.80% Inst Trans-4.24% Short Ratio4.99 Perf Half Y15.62%
Book/sh7.56 P/B22.26 EPS next Y50.32% ROA-9.60% Target Price176.88 Perf Year28.50%
Cash/sh15.12 P/C11.13 EPS next 5Y- ROE-26.40% 52W Range105.05 - 169.46 Perf YTD40.47%
Dividend- P/FCF392.08 EPS past 5Y-28.10% ROI-11.10% 52W High1.47% Beta0.73
Dividend %- Quick Ratio5.60 Sales past 5Y45.20% Gross Margin63.00% 52W Low63.69% ATR5.97
Employees2800 Current Ratio6.10 Sales Q/Q38.70% Oper. Margin-13.60% RSI (14)68.70 Volatility3.53% 3.91%
OptionableYes Debt/Eq1.53 EPS Q/Q-134.10% Profit Margin-14.00% Rel Volume0.72 Prev Close168.28
ShortableYes LT Debt/Eq1.52 EarningsJul 31 AMC Payout- Avg Volume1.06M Price171.95
Recom1.80 SMA2011.62% SMA5013.94% SMA20027.21% Volume336,411 Change2.18%
Nov-28-18Initiated UBS Neutral $135
Oct-19-18Upgrade Goldman Sell → Neutral
Sep-12-18Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18Reiterated Canaccord Genuity Buy $105 → $125
Jul-02-18Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18Upgrade JP Morgan Neutral → Overweight
May-11-18Initiated BofA/Merrill Buy $100
May-03-18Reiterated Canaccord Genuity Buy $81 → $85
Apr-04-18Initiated Guggenheim Neutral
Apr-04-18Initiated Goldman Sell $57
Mar-23-18Upgrade Robert W. Baird Neutral → Outperform
Jan-04-18Downgrade Northland Capital Market Perform → Under Perform
Sep-28-17Reiterated Wedbush Outperform $85 → $76
Sep-28-17Downgrade Raymond James Outperform → Mkt Perform
Sep-28-17Downgrade Northland Capital Outperform → Market Perform
Sep-28-17Downgrade JP Morgan Overweight → Neutral
Sep-26-17Initiated Northland Capital Outperform $85
Sep-15-17Initiated Barclays Equal Weight $76
May-22-17Resumed Piper Jaffray Overweight
May-03-17Reiterated Canaccord Genuity Buy $95 → $90
Aug-20-19 06:00AM  Forget the Inverted Yield Curve, These 3 Stocks Just Hit All-Time Highs Motley Fool
Aug-19-19 09:15PM  Dexcom Inc (DXCM) President, CEO and Chairman Kevin R Sayer Sold $1.6 million of Shares GuruFocus.com
Aug-15-19 05:10PM  Edited Transcript of DXCM earnings conference call or presentation 31-Jul-19 8:30pm GMT Thomson Reuters StreetEvents
05:09PM  Edited Transcript of DXCM earnings conference call or presentation 1-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
05:09PM  Edited Transcript of DXCM earnings conference call or presentation 27-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
01:55PM  Edited Transcript of DXCM earnings conference call or presentation 6-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
01:07PM  Edited Transcript of DXCM earnings conference call or presentation 1-May-19 8:30pm GMT Thomson Reuters StreetEvents
01:06PM  Edited Transcript of DXCM earnings conference call or presentation 21-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Aug-06-19 03:09PM  Why Insulet's Shares Are Rocketing 20.8% Higher Today Motley Fool
Aug-03-19 04:05PM  5 Top Medical Device Stocks to Buy Now Motley Fool
Aug-02-19 09:27AM  DexCom (DXCM) Q2 Earnings and Revenues Surpass Estimates Zacks
09:15AM  DexCom (DXCM) Hits 52-Week High, Can the Run Continue? Zacks
08:30AM  Dexcom Announces Upcoming Conference Presentations Business Wire
Aug-01-19 09:29AM  Does DexCom, Inc.'s (NASDAQ:DXCM) CEO Pay Matter? Simply Wall St. -5.45%
07:13AM  Dow Jones Futures: Three Stock Market Lessons From Wednesday's Sell-Off; 5 Stocks Moving On Earnings Investor's Business Daily
06:00AM  What You'll Want to Know About DexCom's Q2 Earnings Results Motley Fool
03:23AM  DexCom (DXCM) Q2 2019 Earnings Call Transcript Motley Fool
Jul-31-19 05:19PM  This Medtech Just Posted A Surprise Quarterly Gain So Why Did It Dive? Investor's Business Daily
04:03PM  Dexcom Reports Second Quarter 2019 Financial Results Business Wire
07:06AM  The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster Benzinga
Jul-30-19 09:40AM  Medical Products' Earnings Roster for Jul 31: MCK, HOLX & More Zacks
Jul-25-19 07:37AM  What's in the Offing for DexCom's (DXCM) Earnings in Q2? Zacks
Jul-24-19 10:32AM  DexCom (DXCM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-16-19 06:00AM  FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars Reuters
Jul-15-19 10:00AM  3 Top Diabetes Stocks to Watch in July Motley Fool
Jul-12-19 01:06PM  3 Internet of Things Stocks to Buy for July Zacks
Jul-11-19 09:00AM  All You Need to Know About DexCom (DXCM) Rating Upgrade to Strong Buy Zacks
Jul-09-19 08:15PM  Dexcom Inc (DXCM) President, CEO and Chairman Kevin R Sayer Sold $877,500 of Shares GuruFocus.com
12:22PM  Profit from Surprise in Q2 2019 Earnings Season Zacks
Jul-05-19 09:25AM  Will MedTech Ease Investors' Concern & Outperform? 4 Picks Zacks
Jul-03-19 08:00AM  ETF & Stock Winners of Longest US Economic Expansion Zacks
Jul-02-19 09:00AM  Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time Business Wire
Jun-26-19 12:57PM  Need To Know: DexCom, Inc. (NASDAQ:DXCM) Insiders Have Been Selling Shares Simply Wall St.
Jun-21-19 04:10PM  IBD Stock Of The Day: Dexcom Nears Breakout On Medical Device Heyday Investor's Business Daily
Jun-17-19 05:52PM  Heres What Hedge Funds Think About DexCom, Inc. (DXCM) Insider Monkey
10:36AM  Altair Engineering, Netgear, Fitbit, Microsoft and DexCom highlighted as Zacks Bull and Bear of the Day Zacks
10:22AM  The Zacks Analyst Blog Highlights: JinkoSolar, Salem Media, Ciena, DexCom and Zumiez Zacks
Jun-14-19 01:27PM  3 "Internet of Things" Stocks to Buy Right Now Zacks
08:43AM  5 Top-Ranked Stocks Crushing the Market in June Zacks
08:09AM  Dexcom Looks Like It Can Finally Break Out on the Topside TheStreet.com
Jun-10-19 04:45PM  Why DexCom Stock Jumped Today Motley Fool +9.89%
Jun-07-19 08:26AM  DexCom and Companion Medical Collaboration to Support CGM Zacks
Jun-06-19 09:25AM  Here's Why You Should Invest in DexCom (DXCM) Stock Now Zacks
08:45AM  Dexcom and Companion Medical Announce Collaboration to Integrate Dexcom CGM Data and InPen Insulin Data Business Wire
May-31-19 03:51PM  Is DexCom's (NASDAQ:DXCM) 232% Share Price Increase Well Justified? Simply Wall St.
09:31AM  Why Is DexCom (DXCM) Down 0.4% Since Last Earnings Report? Zacks
May-15-19 02:21PM  3 "Internet of Things" Stocks to Buy Right Now Zacks
May-02-19 06:24PM  DexCom (DXCM) Q1 2019 Earnings Call Transcript Motley Fool
09:51AM  DexCom (DXCM) Beats on Q1 Earnings, Hikes '19 Guidance Zacks
May-01-19 05:25PM  DexCom (DXCM) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:16PM  DexCom: 1Q Earnings Snapshot Associated Press
04:02PM  Dexcom Reports First Quarter 2019 Financial Results Business Wire
11:46AM  DexCom Q1 Earnings Preview Benzinga
Apr-26-19 07:57AM  Jim Cramer Gives His Opinion On Sarepta, Blackstone, Tractor Supply And More Benzinga +5.12%
Apr-25-19 09:30PM  Cramer Remix: I think the stock market's biggest risk right now is the current IPO cycle CNBC
07:07PM  Cramer's lightning round: This stock can benefit from Intel's pullback CNBC
03:29PM  DexCom (DXCM) to Report Q1 Earnings: What's in the Offing? Zacks
Apr-24-19 10:33AM  DexCom (DXCM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-23-19 10:58AM  Quest Diagnostics (DGX) Q1 Earnings Top Mark, Margins Down Zacks
Apr-20-19 05:00PM  How Marijuana Legalization Affected OrganiGram and Aphria's Latest Results Motley Fool
Apr-17-19 11:54AM  Abbott (ABT) Q1 Earnings Beat Estimates, Organic Sales Solid Zacks -5.42%
Apr-13-19 07:30PM  3 Top Diabetes Stocks to Watch in April Motley Fool
Apr-12-19 08:33AM  Top IoT Stocks to Buy in 2019 Motley Fool
Apr-11-19 05:45PM  DexCom (DXCM) Stock Moves 0.35%: What You Should Know Zacks
12:23PM  5 Top Medical Device Stocks for 2019 Motley Fool
Apr-05-19 05:45PM  DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know Zacks
Apr-04-19 09:12PM  Hedge Funds Havent Been This Bullish On DexCom, Inc. (DXCM) Since 2015 Insider Monkey
06:21PM  Here's Why DexCom Shares Slumped 14.5% in March Motley Fool
Apr-03-19 04:05PM  Dexcom Schedules First Quarter 2019 Earnings Release and Conference Call for May 1, 2019 at 4:30 p.m. Eastern Time Business Wire
Apr-01-19 10:58AM  Here's Why You Should Retain ABIOMED Stock in Your Portfolio Zacks
10:40AM  Integer Holdings Gets Positive Outlook & B+ Rating From S&P Zacks
Mar-27-19 08:34AM  Varian Medical (VAR) Collaborates With Korea-Based Hospital Zacks
Mar-26-19 12:00PM  Allscripts' FollowMyHealth Partners Ephraim McDowell Health Zacks
11:48AM  Fresenius Medical to Make Huge Investments, Competition Rife Zacks
Mar-25-19 10:53AM  AMN Healthcare Down on Soft Locum Tenens Business, Dull View Zacks
10:49AM  BD Remains Confident About LUTONIX DCB Despite FDA Letter Zacks
06:46AM  3 Big Stock Charts for Monday: Twitter, UnitedHealth Group and Philip Morris InvestorPlace
Mar-23-19 09:30AM  DexCom (DXCM) Down 11.8% Since Last Earnings Report: Can It Rebound? Zacks
Mar-22-19 04:54PM  HMS Holdings Gains on PI & TPM Solutions, Competition Rife Zacks -9.24%
03:34PM  Here's Why You Should Retain Ecolab Stock in Your Portfolio Zacks
03:19PM  Here's Why DexCom Shares Are Dropping Today Motley Fool
10:33AM  DexCom, comScore, Lululemon, Nike and Under Armour highlighted as Zacks Bull and Bear of the Day Zacks
06:01AM  Bull of the Day: DexCom (DXCM) Zacks
Mar-21-19 04:28PM  Here's Why You Should Hold on to Cerner (CERN) Stock for Now Zacks
03:46PM  Spruce Point: Dexcom Could Fall 45-60% Benzinga
03:45PM  Heres What the Apple Watch Means for AAPL Stock InvestorPlace
Mar-20-19 09:30AM  Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Zacks
Mar-19-19 10:30AM  Inogen's Prospects in Europe Solid Amid Trade-Related Tension Zacks
Mar-18-19 09:08AM  Veeva Systems (VEEV) Gains From Solid Results for Fiscal Q4 Zacks
Mar-16-19 12:00PM  3 Top Diabetes Stocks to Watch in March Motley Fool
Mar-12-19 09:15AM  Tech Snaps Market Out of Slump Zacks
08:48AM  Varian & Tata Trust Tie Up to Boost Radiotherapy in India Zacks
07:00AM  The Zacks Analyst Blog Highlights: Jazz Pharmaceuticals, Lululemon Athletica, ABIOMED and DexCom Zacks
Mar-11-19 09:19AM  The Best And Worst Stocks of the 10-Year Bull Market Zacks
08:48AM  HOLX vs DXCM: Which MedTech Stock is a Better Investment Pick? Zacks
Mar-08-19 10:46AM  Is DexCom a Buy? Motley Fool
08:52AM  Align Technology-Benco Dental Deal to Expand iTero Reach Zacks
Mar-07-19 08:47AM  GNC Holdings to Expand Portfolio With Alani Nutrition Deal Zacks
08:38AM  Tandem's Global Growth a Boost, Operating Losses a Bane Zacks
Mar-06-19 08:57AM  GNC Forms Joint Venture With IVC to Improve Cost Efficiency Zacks
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAYER KEVIN RPresident, CEO and ChairmanAug 15Sale156.1210,0001,561,167278,100Aug 19 06:20 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJul 23Sale153.562,016309,5704,032Jul 24 06:15 PM
SAYER KEVIN RPresident, CEO and ChairmanJul 08Sale146.256,000877,476288,100Jul 09 06:57 PM
ALTMAN STEVEN RDirectorJul 01Sale151.622,500379,05251,304Jul 02 09:38 PM
Pacelli Steven RobertEVP Strategy and Corporate DevJun 24Sale149.653,116466,30489,658Jun 25 05:21 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJun 24Sale149.622,016301,6266,048Jun 25 05:21 PM
AUGUSTINOS NICHOLASDirectorJun 14Sale146.321,208176,7559,270Jun 17 05:50 PM
Leach Jacob StevenEVP Chief Technology OfficerJun 13Sale145.325,099741,008115,781Jun 14 05:32 PM
Murphy Patrick MichaelSVP Legal AffairsJun 10Sale127.0340050,81235,460Jun 11 06:12 PM
SAYER KEVIN RPresident, CEO and ChairmanJun 10Sale132.746,000796,444294,100Jun 11 06:12 PM
Balo Andrew K*Jun 05Sale125.007,825978,12569,392Jun 06 05:35 PM
Abbey DonaldEVP Quality and Regulatory AffJun 03Sale121.089,0301,093,35286,393Jun 04 05:37 PM
Blackford Quentin S.EVP Chief Financial OfficerMay 29Sale118.958,8741,055,52791,740May 30 04:56 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMay 23Sale117.292,016236,4528,064May 24 05:09 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMay 23Sale116.713,597419,81692,774May 24 05:09 PM
FOLETTA MARK GDirectorMay 15Sale121.891,000121,89513,095May 17 06:22 PM
SAYER KEVIN RPresident, CEO and ChairmanMay 13Sale115.736,000694,365300,100May 14 06:47 PM
Murphy Patrick MichaelSVP Legal AffairsMay 10Sale116.9240046,76835,860May 13 05:51 PM
Leach Jacob StevenEVP Chief Technology OfficerApr 24Option Exercise7.274,79734,874120,880Apr 25 06:06 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerApr 23Sale116.982,016235,83810,080Apr 24 07:58 PM
Pacelli Steven RobertEVP Strategy and Corporate DevApr 23Sale116.613,596419,32996,371Apr 24 07:58 PM
FOLETTA MARK GDirectorApr 15Sale118.981,000118,97714,095Apr 17 05:20 PM
SAYER KEVIN RPresident, CEO and ChairmanApr 15Sale118.916,000713,471306,100Apr 16 05:37 PM
Murphy Patrick MichaelSVP Legal AffairsApr 10Sale115.0540046,02036,260Apr 12 05:50 PM
ALTMAN STEVEN RDirectorApr 01Sale119.602,500298,99950,355Apr 02 07:09 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 25Sale127.382,016256,78912,096Mar 27 05:40 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 22Sale140.043,596503,57199,967Mar 26 06:25 PM
FOLETTA MARK GDirectorMar 15Sale150.281,000150,27915,095Mar 19 06:24 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 12Sale142.7910,8111,543,726103,913Mar 13 07:01 PM
SAYER KEVIN RPresident, CEO and ChairmanMar 12Sale142.7926,5663,793,418312,100Mar 13 07:01 PM
Balo Andrew K*Mar 12Sale142.7910,9171,558,86277,217Mar 13 07:00 PM
Blackford Quentin S.EVP Chief Financial OfficerMar 12Sale142.795,358765,081100,614Mar 13 07:00 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 12Sale142.7910,8111,543,72672,570Mar 13 07:00 PM
Leach Jacob StevenEVP Chief Technology OfficerMar 12Sale142.798,5551,221,587116,083Mar 13 07:00 PM
MOY JEFFREYSVP OperationsMar 12Sale142.798,5311,218,16027,358Mar 13 07:01 PM
Murphy Patrick MichaelSVP Legal AffairsMar 12Sale142.793,962565,74336,660Mar 13 07:01 PM
Abbey DonaldEVP Quality and Regulatory AffMar 12Sale142.797,6531,092,78995,423Mar 13 06:59 PM
ACE HEATHER SSVP Human ResourcesMar 12Sale142.795,793827,19566,334Mar 13 07:00 PM
ACE HEATHER SSVP Human ResourcesMar 11Sale143.024,668667,63772,127Mar 13 07:00 PM
SAYER KEVIN RPresident, CEO and ChairmanMar 11Sale142.986,000857,890338,666Mar 13 07:01 PM
Murphy Patrick MichaelSVP Legal AffairsMar 08Sale141.5640056,62428,908Mar 11 08:46 PM
Pacelli Steven RobertEVP Strategy and Corporate DevFeb 22Sale144.671,667241,15799,737Feb 26 07:58 PM
FOLETTA MARK GDirectorFeb 15Sale148.721,000148,72316,095Feb 20 05:01 PM
SAYER KEVIN RPresident, CEO and ChairmanFeb 11Sale148.906,000893,400308,837Feb 13 07:23 PM
Murphy Patrick MichaelSVP Legal AffairsFeb 08Sale142.7640057,10429,308Feb 12 04:46 PM
Murphy Patrick MichaelSVP Legal AffairsFeb 08Sale142.7640057,10429,308Feb 12 09:24 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 23Sale149.743,114466,303101,404Jan 24 05:46 PM
KAHN BARBARADirectorJan 14Sale142.3010,6311,512,82716,817Jan 16 06:08 PM
SAYER KEVIN RPresident, CEO & ChairmanJan 14Sale140.996,000845,930314,837Jan 15 05:30 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffJan 10Sale138.7540055,50029,708Jan 14 09:42 PM
SKYLER JAY SDirectorJan 02Option Exercise4.5825,806118,19152,616Jan 04 05:03 PM
ALTMAN STEVEN RDirectorJan 02Sale117.042,500292,59352,855Jan 04 05:03 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerDec 21Sale109.341,510165,10114,112Dec 26 08:33 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Dec 21Sale109.413,114340,700104,518Dec 26 08:22 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalDec 14Sale121.235,000606,16773,105Dec 18 06:34 PM
SAYER KEVIN RPresident, CEO & ChairmanDec 10Option Exercise4.5811,16251,122331,999Dec 12 09:08 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffDec 10Sale121.9040048,76030,108Dec 12 09:09 PM
SAYER KEVIN RPresident, CEO & ChairmanDec 10Sale121.6711,1621,358,041320,837Dec 12 09:08 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerNov 23Sale121.351,736210,66415,622Nov 27 06:27 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Nov 23Sale121.423,114378,105107,632Nov 27 06:27 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalNov 14Sale143.135,000715,66478,105Nov 16 05:14 PM
SAYER KEVIN RPresident, CEO & ChairmanNov 12Option Exercise4.5811,16151,117331,998Nov 14 07:29 PM
SAYER KEVIN RPresident, CEO & ChairmanNov 12Sale146.4311,1611,634,284320,837Nov 14 07:29 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffNov 09Sale148.1140059,24430,508Nov 13 08:14 PM
Abbey DonaldEVP, Quality & Regulatory AfrsNov 09Sale149.3010,5501,575,15988,089Nov 13 08:13 PM
ACE HEATHER SSVP Human ResourcesNov 09Sale147.324,258627,29465,081Nov 13 08:14 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Oct 23Sale128.853,114401,253110,746Oct 25 08:58 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerOct 23Sale128.721,736223,46617,358Oct 25 08:59 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalOct 12Sale124.795,000623,93483,105Oct 16 05:27 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffOct 10Sale122.2040048,88030,908Oct 12 04:11 PM
SAYER KEVIN RPresident, CEO & ChairmanOct 08Option Exercise4.5811,16151,117331,998Oct 10 07:48 PM
SAYER KEVIN RPresident, CEO & ChairmanOct 08Sale124.7611,1611,392,433320,837Oct 10 07:48 PM
ALTMAN STEVEN RDirectorOct 01Sale135.652,500339,13455,355Oct 03 04:50 PM
Leach Jacob StevenChief Technology OfficerSep 28Sale143.9547,6006,852,1390Oct 01 07:10 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerSep 24Sale141.201,736245,12919,094Sep 26 08:32 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 24Sale141.253,114439,841113,860Sep 26 08:32 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalSep 14Sale145.175,000725,85188,105Sep 18 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentSep 12Option Exercise5.9215,00088,800109,284Sep 14 04:35 PM
Blackford Quentin S.EVP, CFO, PFO & PAOSep 11Sale147.048,4401,241,02887,131Sep 13 09:48 PM
SAYER KEVIN RPresident, CEO & ChairmanSep 10Option Exercise4.5811,16151,117346,332Sep 12 09:17 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerSep 10Sale143.765,483788,21066,804Sep 12 09:22 PM
MOY JEFFREYSVP, OperationsSep 10Sale143.355,736822,25616,711Sep 12 09:22 PM
MOY JEFFREYSVP, OperationsSep 10Sale143.764,594660,41163,920Sep 12 09:22 PM
Murphy Patrick MichaelVP, Legal Aff & Chf Compl OfcrSep 10Sale143.692,372340,82531,308Sep 12 09:20 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 10Sale143.765,483788,210116,974Sep 12 09:21 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalSep 10Sale143.765,587803,16093,105Sep 12 09:21 PM
ACE HEATHER SSVP Human ResourcesSep 10Sale143.761,832263,36069,339Sep 12 09:19 PM
Leach Jacob StevenSVP, Research & DevelopmentSep 10Sale143.764,614663,28694,284Sep 12 09:20 PM
Abbey DonaldEVP, Quality & Regulatory AfrsSep 10Sale143.762,303331,06898,639Sep 12 09:19 PM
Blackford Quentin S.EVP, CFO, PFO & PAOSep 10Sale143.767,1491,027,70695,571Sep 12 09:18 PM
SAYER KEVIN RPresident, CEO & ChairmanSep 10Sale143.6225,4953,661,573320,837Sep 12 09:17 PM
Leach Jacob StevenSVP, Research & DevelopmentAug 24Option Exercise4.5220,57792,941109,455Aug 28 06:58 PM
ALTMAN STEVEN RDirectorAug 24Sale136.475,000682,3590Aug 28 08:32 PM
FOLETTA MARK GDirectorAug 24Sale137.501,000137,50317,095Aug 28 07:01 PM
Leach Jacob StevenSVP, Research & DevelopmentAug 24Sale138.3220,5772,846,15598,878Aug 28 06:58 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 23Sale139.963,114435,843122,457Aug 27 05:20 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerAug 23Sale140.032,584361,8330Aug 27 05:20 PM